Area of research
Pharmacy · Public Health, Environmental and Occupational Health
Research interest
Research interests include Obesity and Health Practices, Obesity, Physical Activity, Diet, Bariatric Surgery and Outcomes, and Pharmacology and Obesity Treatment.
Ensuring Competent Care Provision for Children and Adolescents With Obesity in the Primary Care Setting.
One size does not fit all: Qualitative interviews with individuals with overweight or obesity and healthcare providers on navigating and supporting weight management.
Racial and Ethnic Differences Between Waist Circumference and BMI in Identifying Obesity.
ChatGPT for obesity management: a review of evidence, potential challenges, and clinical implications.
Consumer Risk in the Compounded GLP-1 Boom: Why Compounded GLP-1s Demand Urgent Public Health Action.
GLP-1 Receptor Agonist Use Across Preconception, Pregnancy, and the Postpartum Periods.
Responsible Public Health Risk Communication: A New Framework for Consumer Safety.
Diagnostic Performance of BMI and Waist Circumference in Detecting Excess Adiposity.
Definition and diagnostic criteria of clinical obesity
Nutritional priorities to support <scp>GLP</scp>‐1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society
Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society
Dietitians' role in obesity care: insights from the Academy of Nutrition and Dietetics.
Personalized Lifestyle Interventions for Prevention and Treatment of Obesity-Related Cancers: A Call to Action.
Law and Policy Efforts to Dismantle Diversity, Equity, and Inclusion.
Agreement between self-reported and measured weight, height, and derived BMI by educational attainment across racial and ethnic groups of US women.
Association of Overweight and Obesity With Financial Burden
Flourishing as a Pathway to Well-Being in Obesity Care.
Inflation as a gut health crisis: The SAFEGUARD framework.
Association of Overweight and Obesity With Financial Burden.
Racial and ethnic disparities in clinical trials for pediatric obesity.
Changing the global obesity narrative to recognize and reduce weight stigma: A position statement from the World Obesity Federation.
GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review.
Inequalities in the provision of GLP-1 receptor agonists for the treatment of obesity.
Ending Weight Stigma to Advance Health Equity
Ending Weight Stigma to Advance Health Equity
Body Composition in Anti-Obesity Medication Trials—Beyond Scales
Body Mass Index Thresholds for Asians: A Race Correction in Need of Correction?
Body Composition in Anti-Obesity Medication Trials-Beyond Scales.